SEC-sourced researchBeta
TLSIW
TriSalus Life Sciences, Inc.
Company comparison ↗
Data passport
- CIK
- 0001826667
- Exchange
- Nasdaq
- Business activity
- — · SIC 3841
- Financial inputs
- 6/6
- Filing date
- Sep 22, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 29,431,000.0000 | Mar 5, 2026 |
| December 2025 | 45,151,000.0000 | Mar 5, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 45,151,000.0000 | -39,227,000.0000 | -18,012,000.0000 | 35,331,000.0000 | 69,192,000.0000 | Mar 5, 2026 |
| December 2024 | 29,431,000.0000 | -30,045,000.0000 | -40,843,000.0000 | 23,971,000.0000 | 49,865,000.0000 | Mar 5, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $45.15M | December 2025 | Mar 5, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $29.43M | December 2024 | Mar 5, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$39.23M | December 2025 | Mar 5, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$18.01M | December 2025 | Mar 5, 2026 | 10-K |
| Total assetsAssets | $35.33M | December 2025 | Mar 5, 2026 | 10-K |
| Total liabilitiesLiabilities | $69.19M | December 2025 | Mar 5, 2026 | 10-K |